Loading clinical trials...
Loading clinical trials...
The main objective of this study is to evaluate the tumor objective response rate (ORR) assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in participants who receive sotor...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Amgen
NCT07444437 · Non-Small Cell Lung Cancer
NCT07489716 · Non-Small Cell Lung Cancer
NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more
NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
Alabama Oncology
Birmingham, Alabama
Arizona Oncology Associates Professional Corporation
Tucson, Arizona
City of Hope at Long Beach Elm
Duarte, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions